Teikyo University Hospital

Itabashi-ku 173-8606

2 studies enrolling now · 13 studies all time

What they study most

Acute Coronary Syndrome, Arthritis, Psoriatic, Atrial Fibrillation, Behçet's Syndrome, Dermatitis, Atopic, Eczema, Metastatic Cholangiocarcinoma, Multifocal Motor Neuropathy, Myasthenia Gravis, Plaque Psoriasis, UC (Urothelial Cancer), Unresectable Cholangiocarcinoma

Studies at this site

A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis — Recruiting now
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK) — Recruiting now
A Study of JNJ-95475939 in the Treatment of Participants With Moderate to Severe Atopic Dermatitis (AD) — Stopped early
A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis — Running, not enrolling
A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis — Running, not enrolling
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome — Completed
A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis — Running, not enrolling
A Prospective Longitudinal Study in Adults With Multifocal Motor Neuropathy — Running, not enrolling
A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma — Stopped early
A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201) — Completed
A Study to Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Atopic Dermatitis — Completed
A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behçet's Disease — Completed